Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can magnetic pulses plus writing tame trauma?

NCT ID NCT07567261

Symptom relief Sponsor: Servicio Canario de Salud Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining repetitive transcranial magnetic stimulation (rTMS) with expressive writing can reduce post-traumatic stress symptoms in adults. Forty-five participants who have experienced a traumatic event will be split into three groups: rTMS before writing, rTMS after writing, or a sham procedure. They will complete questionnaires and have heart rate and skin responses measured to see which timing works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS) and expressive writing
What this could lead to
If it works, this could point toward a new, non-drug treatment for post-traumatic stress symptoms that combines brain stimulation with emotional writing.
What could go wrong
This is a very small early study (45 people) with no phase, so results may not be conclusive. The sham group helps, but the effect of timing is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be between 18 and 65 years of age. * Have experienced at least one traumatic or highly stressful event, regardless of how much time has passed since the event occurred. * Present a score ≥ 24 on the Revised Impact of Event Scale (IES-R). * Have post-traumatic stress symptoms that are not better explained by another clinical condition or mental disorder. Exclusion Criteria: * History of epilepsy, seizures, or convulsions. * Presence of intracranial or cranial metal incompatible with rTMS. * History of severe traumatic brain injury. * Pregnancy or reasonable possibility of pregnancy. * Cochlear implants or internal pulse generators. * Use of medication that lowers the seizure threshold. * Current suicidal ideation or behaviour, or recent suicidal ideation within the past month. * Other medical or psychiatric conditions that contraindicate the use of rTMS. * Any condition that prevents participation in any of the study interventions. * Currently receiving psychological and/or pharmacological treatment for PTSD, acute stress, or another disorder that could account for post-traumatic stress symptoms. * Failure to provide written informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy adults

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Instituto Universitario de Neurociencias (IUNE) de la Universidad de La Laguna (ULL)

    San Cristóbal de La Laguna, Santa Cruz de Tenerife, 38200, Spain

  • Servicio de Evaluación del Servicio Canario de Salud

    Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38109, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.